Canada vs Norway: Cause of death, by non-communicable diseases, ages 60+, female
Canada
87.8%
in 2021
Norway
87.9%
in 2021
Canada rank
16th
Norway rank
15th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Canada
- Norway
How they compare
Norway currently reports 87.9% against 87.8% in Canada, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Canada ahead.
Canada ranks 16th and Norway ranks 15th of 185 countries.
Across the 3 decades both report, Canada averaged higher in 2 and Norway in 1.
Head to head by decade
| Decade | Canada | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.8% | 87.6% | 5.1% | Canada |
| 2010s | 91.0% | 87.9% | 3.1% | Canada |
| 2020s | 86.7% | 87.7% | 1.0% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Canada or Norway?
- Norway, at 87.9% against 87.8% in Canada as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Canada and Norway?
- 0.1%, with Norway ahead.
- How many years of comparable data are there for Canada and Norway?
- 6 years are reported by both, from 2000 to 2021.
- How do Canada and Norway rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Canada ranks 16th and Norway ranks 15th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.